Stance Capital’s Corteva CTVA Stock Holding History

Stance Capital’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-15	Closed	-$854	–	107
2024 Q4	$854	Buy	+15	New	+$887	﹤0.01%	229

Other funds holding CTVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

IFP

Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Stance Capital's CTVA Position: Q1 2025 in Review

Stance Capital sold out of Corteva (CTVA) in Q1 2025, closing a stake of 15 shares — an estimated $854 sold.

Stance Capital first reported a position in CTVA in Q4 2024 and held it in 1 quarter. The position peaked at $854 in Q4 2024. 1,322 funds tracked by Wall St. Rank hold CTVA as of Q1 2025.

Stance Capital reported no remaining Corteva position as of Q1 2025 after selling out during the quarter.
Stance Capital sold 15 Corteva shares in Q1 2025, an estimated $854.
Stance Capital first reported a position in Corteva in Q4 2024 and held it in 1 quarter.
Stance Capital's Corteva position peaked at $854 in Q4 2024.
1,322 funds tracked by Wall St. Rank held Corteva as of Q1 2025.

Based on Stance Capital's 13F filing for Q1 2025, filed 16 May 2025.